At the institute’s Cancer Early Detection Advanced Research Center, Dr. Heller will develop techniques and instruments to diagnosis and examine early signs of cancer. In the past two years, the research center has hired more than 20 people for engineering, biology, informatics and computer science roles, according to Portland Business Journal.
At UC San Diego, Dr. Heller established a bioengineering and nanobiology laboratory and developed biochips that analyze blood for bioindicators of cancer, Portland Business Journal reports. Prior, he co-founded and served as chief technology officer of the diagnostics company Nanogen.
More articles on health IT:
mHealth interventions reduce blood pressure, study finds
Huntington’s Disease Society taps American Well for remote psychology, social work
Dementia apps lack privacy, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
